Association of primary tumor site with mortality in patients receiving bevacizumab and cetuximab for metastatic colorectal cancer

Mayada A. Aljehani; John W. Morgan; Laurel A. Guthrie; Brice Jabo; Majed Ramadan; Khaled Bahjri; Sharon S. Lum; Matthew Selleck; Mark E. Reeves; Carlos Garberoglio; Maheswari Senthil

doi:10.1001/jamasurg.2017.3466

Association of primary tumor site with mortality in patients receiving bevacizumab and cetuximab for metastatic colorectal cancer

Mayada A. Aljehani
, John W. Morgan
, Laurel A. Guthrie
, Brice Jabo
, Majed Ramadan
, Khaled Bahjri
, Sharon S. Lum
, Matthew Selleck
, Mark E. Reeves
, Carlos Garberoglio
, Maheswari Senthil

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	60-67
Number of pages	8
Journal	JAMA Surgery
Volume	153
Issue number	1
DOIs	https://doi.org/10.1001/jamasurg.2017.3466
State	Published - Jan 2018

ASJC Scopus Subject Areas

Surgery

Keywords

Cetuximab/administration & dosage
Bevacizumab/administration & dosage
Humans
Middle Aged
Proto-Oncogene Proteins p21(ras)/genetics
Male
Colorectal Neoplasms/drug therapy
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
California/epidemiology
Aged, 80 and over
Adult
Female
Registries
Aged
Retrospective Studies
Adenocarcinoma/drug therapy
Cohort Studies

Access to Document

10.1001/jamasurg.2017.3466License: Unspecified

OpenUrl availability

Full text

Cite this

@article{2428f1572a2c4e59b7e44e86e4e8875b,

title = "Association of primary tumor site with mortality in patients receiving bevacizumab and cetuximab for metastatic colorectal cancer",

keywords = "Cetuximab/administration \& dosage, Bevacizumab/administration \& dosage, Humans, Middle Aged, Proto-Oncogene Proteins p21(ras)/genetics, Male, Colorectal Neoplasms/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, California/epidemiology, Aged, 80 and over, Adult, Female, Registries, Aged, Retrospective Studies, Adenocarcinoma/drug therapy, Cohort Studies",

author = "Aljehani, \{Mayada A.\} and Morgan, \{John W.\} and Guthrie, \{Laurel A.\} and Brice Jabo and Majed Ramadan and Khaled Bahjri and Lum, \{Sharon S.\} and Matthew Selleck and Reeves, \{Mark E.\} and Carlos Garberoglio and Maheswari Senthil",

year = "2018",

month = jan,

doi = "10.1001/jamasurg.2017.3466",

language = "English",

volume = "153",

pages = "60--67",

journal = "JAMA Surgery",

issn = "2168-6254",

number = "1",

}

TY - JOUR

T1 - Association of primary tumor site with mortality in patients receiving bevacizumab and cetuximab for metastatic colorectal cancer

AU - Aljehani, Mayada A.

AU - Morgan, John W.

AU - Guthrie, Laurel A.

AU - Jabo, Brice

AU - Ramadan, Majed

AU - Bahjri, Khaled

AU - Lum, Sharon S.

AU - Selleck, Matthew

AU - Reeves, Mark E.

AU - Garberoglio, Carlos

AU - Senthil, Maheswari

PY - 2018/1

Y1 - 2018/1

KW - Cetuximab/administration & dosage

KW - Bevacizumab/administration & dosage

KW - Humans

KW - Middle Aged

KW - Proto-Oncogene Proteins p21(ras)/genetics

KW - Male

KW - Colorectal Neoplasms/drug therapy

KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use

KW - California/epidemiology

KW - Aged, 80 and over

KW - Adult

KW - Female

KW - Registries

KW - Aged

KW - Retrospective Studies

KW - Adenocarcinoma/drug therapy

KW - Cohort Studies

UR - https://www.scopus.com/pages/publications/85041133286

UR - https://www.scopus.com/pages/publications/85041133286#tab=citedBy

UR - https://www.mendeley.com/catalogue/4452b99f-7812-3422-ac61-1da3cc4ba23e/

U2 - 10.1001/jamasurg.2017.3466

DO - 10.1001/jamasurg.2017.3466

M3 - Article

C2 - 28975237

SN - 2168-6254

VL - 153

SP - 60

EP - 67

JO - JAMA Surgery

JF - JAMA Surgery

IS - 1

ER -

Association of primary tumor site with mortality in patients receiving bevacizumab and cetuximab for metastatic colorectal cancer

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this